Evidence map›Paper›PMID 25717410›Full record

ArticleAMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science2014

Creation and Validation of an EMR-based Algorithm for Identifying Major Adverse Cardiac Events while on Statins.

Wei-Qi Wei, Qiping Feng, Peter Weeke, William Bush, Magarya S Waitara, Otito F Iwuchukwu, Dan M Roden, Russell A Wilke, Charles M Stein, Joshua C Denny

Abstract read
In one paragraph

Article in AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Biomedical literature-based clinical phenotype definition discovery using large language models.Database : the journal of biological databases and curation · 2025
    Article
  5. Impact of metabolic and weight components on incident asthma using a real-world cohort.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2024
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Wei-Qi WeiDepartment of Biomedical Informatics, Vanderbilt University, Nashville, TN.
Qiping FengDivision of Clinical Pharmacology, Vanderbilt University School of Medicine, Nashville, TN.
Peter WeekeDivision of Clinical Pharmacology, Vanderbilt University School of Medicine, Nashville, TN.
William BushCenter for Human Genetics Research, Vanderbilt University Medical Center, Nashville, TN.
Magarya S WaitaraDivision of Clinical Pharmacology, Vanderbilt University School of Medicine, Nashville, TN.
Otito F IwuchukwuDivision of Clinical Pharmacology, Vanderbilt University School of Medicine, Nashville, TN.
Dan M RodenDivision of Clinical Pharmacology, Vanderbilt University School of Medicine, Nashville, TN ; Oates Institute for Experimental Therapeutics, Vanderbilt University, Nashville, TN ; Office of Personalized Medicine, Vanderbilt University, Nashville, TN.
Russell A WilkeDepartment of Internal Medicine, Sanford Healthcare, Fargo, ND.
Charles M SteinDivision of Clinical Pharmacology, Vanderbilt University School of Medicine, Nashville, TN.
Joshua C DennyDepartment of Biomedical Informatics, Vanderbilt University, Nashville, TN.

Funding

VANDERBILT UNIVERSITY CTSA FOR PEDIATRIC RESEARCHUL1RR024975 · NCRR · VANDERBILT UNIVERSITY · PI BERNARD, GORDON RAPHAEL · 2007 to 2011
$45.7M
Pharmacogenomics of Arrhythmia TherapyU19HL065962 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RODEN, DAN M · 2010 to 2014
$17.4M
Pharmacogenomics and Risk of Cardiovascular DiseaseU19HL069757 · NHLBI · CHILDREN'S HOSPITAL & RES CTR AT OAKLAND · PI KRAUSS, RONALD M · 2010 to 2014
$12.8M
CLINICAL PHARMACOLOGY TRAINING PROGRAMT32GM007569 · NIGMS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Bjorn C Knollmann · 1985 to 2026
$12.4M
From GWAS to PheWAS: Scanning the EMR Phenome for Gene-disease AssociationsR01LM010685 · NLM · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BASTARACHE, LISA · 2011 to 2022
$6.3M
NCRR NIH HHS UL1 RR024975NHLBI NIH HHS U19 HL065962NHLBI NIH HHS U19 HL069757NIGMS NIH HHS T32 GM007569NLM NIH HHS R01 LM010685
6 · The paper itself

Abstract

Statin medications are often prescribed to ameliorate a patient's risk of cardiovascular events due in part to cholesterol reduction. We developed and evaluated an algorithm that can accurately identify subjects with major adverse cardiac events (MACE) while on statins using electronic medical record (EMR) data. The algorithm also identifies subjects experiencing their first MACE while on statins for primary prevention. The algorithm achieved 90% to 97% PPVs in identification of MACE cases as compared against physician review. By applying the algorithm to EMR data in BioVU, cases and controls were identified and used subsequently to replicate known associations with eight genetic variants. We replicated 6/8 previously reported genetic associations with cardiovascular diseases or lipid metabolism disorders. Our results demonstrated that the algorithm can be used to accurately identify subjects with MACE and MACE while on statins. Consequently, future e studies can be conducted to investigate and validate the relationship between statins and MACE using real-world clinical data.

Identifiers

PMID25717410
PMCPMC4333709

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.